Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Fishman

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Molecular Carcinogenesis|February 10, 2016
First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrixGali Epstein Shochet, Liat Drucker, Meir Pomeranz, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 2, 2021
Walking to a better future? Postoperative ambulation after cesarean delivery and complications: A prospective studyOffra Engel, Einat Haikin Herzberger, Yael Yagur, et al.
Menopause (New York, N.Y.)|March 20, 2019
Conservative management for postmenopausal women with tubo-ovarian abscessYael Yagur, Omer Weitzner, Gili Man-El, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2012
BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell linesKeren Amichay, Debora Kidron, Zohar Attias-Geva, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapyZohar Attias-Geva, Itay Bentov, Dvora Kidron, et al.
Diagnostic Cytopathology|June 2, 2011
Screening for cervical neoplasia: a community-based trial comparing Pap staining, human papilloma virus testing, and the new bi-functional Celldetect® stainPavel Idelevich, Don Kristt, Eduardo Schechter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 25, 2018
Impact of BRCA mutations on outcomes among patients with serous endometrial cancerYfat Kadan, Oshrat Raviv, Yakir Segev, et al.
Archives of Gynecology and Obstetrics|February 4, 2017
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancerOfer Lavie, David Edelman, Tally Levy, et al.
Gynecologic Oncology|September 8, 2004
The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignanciesDan Grisaru, Benny Almog, Charles Levine, et al.
BMC Women'S Health|December 18, 2022
Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapyOmer Weitzner, Yael Yagur, Yfat Kadan, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Molecular Carcinogenesis|February 10, 2016
First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrixGali Epstein Shochet, Liat Drucker, Meir Pomeranz, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 2, 2021
Walking to a better future? Postoperative ambulation after cesarean delivery and complications: A prospective studyOffra Engel, Einat Haikin Herzberger, Yael Yagur, et al.
Menopause (New York, N.Y.)|March 20, 2019
Conservative management for postmenopausal women with tubo-ovarian abscessYael Yagur, Omer Weitzner, Gili Man-El, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 29, 2012
BRCA1 is expressed in uterine serous carcinoma (USC) and controls insulin-like growth factor I receptor (IGF-IR) gene expression in USC cell linesKeren Amichay, Debora Kidron, Zohar Attias-Geva, et al.
European Journal of Cancer (Oxford, England : 1990)|October 29, 2011
p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapyZohar Attias-Geva, Itay Bentov, Dvora Kidron, et al.
Diagnostic Cytopathology|June 2, 2011
Screening for cervical neoplasia: a community-based trial comparing Pap staining, human papilloma virus testing, and the new bi-functional Celldetect® stainPavel Idelevich, Don Kristt, Eduardo Schechter, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 25, 2018
Impact of BRCA mutations on outcomes among patients with serous endometrial cancerYfat Kadan, Oshrat Raviv, Yakir Segev, et al.
Archives of Gynecology and Obstetrics|February 4, 2017
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancerOfer Lavie, David Edelman, Tally Levy, et al.
Gynecologic Oncology|September 8, 2004
The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignanciesDan Grisaru, Benny Almog, Charles Levine, et al.
BMC Women'S Health|December 18, 2022
Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapyOmer Weitzner, Yael Yagur, Yfat Kadan, et al.
Pageof 8